KKR-backed Ajax Health and Boston Scientific formed FlowMod.

KKR-backed Ajax Health, a company specializing in medical technology development, and Boston Scientific, a manufacturer of medical devices, formed FlowMod, a company focused on treating heart failure. Financial terms were not disclosed. "On the heels of the Cortex transaction with Boston Scientific, we are thrilled to pursue this new path in interventional heart failure and the benefits it may bring to the millions of patients affected by this disease each year. Through this collaboration, we intend to bring a differentiated solution to physicians and their patients that we believe will make a positive impact on how heart failure is treated," Duke Rohlen, Ajax Health Chief Executive Officer.